Linshom Medical wins $3.5M NIH grant for respiratory monitoring

Linshom Medical received a $3.5 million SBIR Phase 2B grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute to advance wireless continuous respiratory monitoring and a multicenter clinical trial. The company says the award will help move patient monitoring away from bedside equipment and measure the economic value of earlier detection of respiratory decline.

Why it matters: - The grant supports technology that could keep respiratory monitoring connected to patients as they move through care settings. - Early detection of respiratory decline can give clinicians more time to intervene before a crisis. - The work could help hospitals better identify at-risk postoperative patients with continuous monitoring instead of relying only on scoring systems.

What happened: - Linshom Medical was awarded a $3.5 million SBIR Phase 2B grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute. - The award will fund engineering work to add wireless capability to Linshom Medical’s monitoring system. - The grant also supports a multicenter clinical trial focused on the medical-economic benefits of early detection and early intervention.

The details: - Linshom Medical said the first phase of the grant will help de-tether patients from bedside monitors. - The company said the goal is portable, continuous respiratory monitoring. - Linshom Medical said the technology is intended to travel with patients throughout their health care journey. - The company said existing evaluation and scoring systems do not work well for identifying patients who will develop respiratory trouble after surgery. - Linshom Medical said at-risk patients need simple, affordable continuous respiratory monitoring for safer outcomes. - CEO Richard Hughen said current systems respond after respiratory decline occurs. - Hughen said a previous study at Ohio State Wexner Medical Center showed the sensor could detect respiratory decline early enough to allow intervention before a crisis develops. - The company’s sensor provides respiratory rate, relative tidal volume and seconds since last breath in real time. - Linshom Medical says the sensor is patented and FDA cleared. - Linshom Medical says it is the first to deliver an operating-room-quality respiratory profile to the patient bedside for continuous, predictive respiratory monitoring.

Between the lines: - The award signals continued federal interest in tools that can predict respiratory deterioration rather than simply react to it. - The clinical trial suggests Linshom Medical is trying to convert technical detection capability into evidence of cost and care impact. - The focus on wireless monitoring points to a broader push to make inpatient monitoring more portable and less tied to fixed equipment.

What’s next: - Linshom Medical plans to use the funding to complete engineering work and launch the multicenter trial. - The company will look to quantify whether earlier detection and intervention improve both clinical and economic outcomes. - Linshom Medical is currently raising a Series A Preferred round of investment. - More information on the NIH award is available here. - More information about the company is available at www.LinshomMedical.com and info@LinshomMedical.com.

The bottom line: - Linshom Medical’s new NIH grant gives the company funding to expand a predictive respiratory monitoring system and test whether earlier alerts can improve care and reduce costs.